# Safety of GlaxoSmithKline (GSK) Biologicals Hepatitis A Vaccine in Korean Population

> **NCT00237991** · — · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 600 (—)

## Conditions studied

- Hepatitis A

## Interventions

- **BIOLOGICAL:** Hepatitis A

## Key facts

- **NCT ID:** NCT00237991
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2005-06
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 600 (—)
- **Last updated:** 2008-10-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00237991

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00237991, "Safety of GlaxoSmithKline (GSK) Biologicals Hepatitis A Vaccine in Korean Population". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00237991. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*